Related Experiment Video
Updated: Dec 27, 2025

Generation of Orthotopic Pancreatic Tumors and Ex vivo Characterization of Tumor-Infiltrating T Cell Cytotoxicity
Published on: December 7, 2019
Programmed Cell Death Ligand Expression Drives Immune Tolerogenesis across the Diverse Subtypes of Neuroendocrine
David J Pinato1, Anu Vallipuram2, Joanne S Evans2
1Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom, david.pinato@imperial.ac.uk.
Introduction:
A comprehensive characterization of the tumour microenvironment is lacking in neuroendocrine tumours (NETs), where programmed cell death-1 receptor-ligand (PD-1/PD-L1) inhibitors are undergoing efficacy testing.
Objective:
We investigated drivers of cancer-related immunosuppression across NETs of various sites and grades using multi-parameter immunohistochemistry and targeted transcriptomic profiling.
Methods:
Tissue microarrays (n = 102) were stained for PD-L1 and 2 and indoleamine deoxygenase-1 (IDO-1) and evaluated in relationship to functional characteristics of tumour-infiltrating T-lymphocytes (TILs) and biomarkers of hypoxia/angiogenesis. PD-L1 expression was tested in circulating tumour cells (CTCs, n = 12) to evaluate its relationship with metastatic dissemination.
Results:
PD-L1 expression was highest in lung NETs (n = 30, p = 0.007), whereas PD-L2 was highest in pancreatic NETs (n = 53, p < 0.001) with no correlation with grade or hypoxia/angiogenesis. PD-L1+ NETs (n = 26, 25%) had greater CD4+/FOXP3+ and CD8+/PD1+ TILs (p < 0.001) and necrosis (p = 0.02). CD4+/FOXP3+ infiltrate had the highest PD-L1/IDO-1 co-expressing tumours (p = 0.006). Grade 3 well-differentiated NETs had lower CD4+/FOXP3+ and CD8+/PD1+ TIL density (p < 0.001), and NanoString immune profiling revealed enrichment of macrophage-related transcripts in cases with poorer prognosis. We identified PD-L1(+) CTC subpopulations in 75% of evaluated patients (n = 12).
Conclusions:
PD-L1 expression correlates with T-cell exhaustion independent of tumour hypoxia and is enhanced in a subpopulation of CTCs, suggesting its relevance to the progression of NETs. These findings support a potential therapeutic role for PD-L1 inhibitors in a subset of NETs.
Insights
Programmed cell death-1 ligand (PD-L1) expression in neuroendocrine tumors (NETs) correlates with T-cell exhaustion and is found in circulating tumor cells. This suggests PD-L1 inhibitors may benefit a subset of NET patients.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Comprehensive characterization of the tumor microenvironment in neuroendocrine tumors (NETs) is lacking.
- Programmed cell death-1 receptor-ligand (PD-1/PD-L1) inhibitors are being tested for NET efficacy.
Purpose of the Study:
- Investigate drivers of cancer-related immunosuppression in NETs.
- Analyze PD-1/PD-L1 expression in relation to tumor characteristics and immune cells.
Main Methods:
- Multi-parameter immunohistochemistry on tissue microarrays (n=102) for PD-L1, PD-L2, and IDO-1.
- Evaluation of tumor-infiltrating lymphocytes (TILs), hypoxia, and angiogenesis biomarkers.
- Targeted transcriptomic profiling and PD-L1 testing in circulating tumor cells (CTCs, n=12).
Main Results:
- PD-L1 expression was highest in lung NETs; PD-L2 was highest in pancreatic NETs.
- PD-L1+ NETs showed increased CD4+/FOXP3+ and CD8+/PD1+ TILs and necrosis.
- PD-L1 expression correlated with T-cell exhaustion, independent of tumor hypoxia.
- PD-L1+ CTC subpopulations were identified in 75% of patients.
Conclusions:
- PD-L1 expression is relevant to NET progression and T-cell exhaustion.
- PD-L1 inhibitors may offer therapeutic potential for a subset of NET patients.
More Related Videos
Related Concept Videos
The Extrinsic Apoptotic Pathway
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Intrinsic Apoptotic Pathway

